English

OPTIMER PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2013-08-07

30 filing records in this dataset, filed from 2007-03-30 to 2013-08-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

19.4 million USD

2013 Q1 · USD

Exact inputs and evidence

Revenue: 19435494 USD Source

Operating margin

-162.03%

2013 Q1 · %

Exact inputs and evidence

Operating Income: -31490924 USD Source
Revenue: 19435494 USD Source

Operating cash flow

-32.8 million USD

2013 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -32838898 USD Source

Free cash flow

-32.9 million USD

2013 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -32838898 USD Source
Capital Expenditure: 38834 USD Source

Cash and cash equivalents: 88 million USD 2013-03-31 Source
Exact value

87964542 USD
Long-term debt including current maturities: Not available
Shares outstanding: 48 million shares 2013-03-31 Source
Exact value

48024010 shares

Reported share-count change

2.70% · 1.26 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46760532 shares · 2012-03-31· Source
48024010 shares · 2013-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

107 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Revenue: 49757000 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 17876000 USD · 2012-07-01 – 2012-09-30 Source
Revenue: 19515000 USD · 2012-10-01 – 2012-12-31 Source
Revenue: 19435494 USD · 2013-01-01 – 2013-03-31 Source

Net income

-17.5 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: -47339742 USD · 2010-01-01 – 2010-12-31 Source
Net income: -35393740 USD · 2010-01-01 – 2010-09-30 Source
Net income: 45132870 USD · 2011-01-01 – 2011-03-31 Source
Net income: -24238846 USD · 2011-04-01 – 2011-06-30 Source
Net income: -26426671 USD · 2011-07-01 – 2011-09-30 Source

Operating cash flow

-44 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Operating cash flow: 28763392 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -27745465 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -4841756 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 28763392 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -38884582 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: -4841756 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -32838898 USD · 2013-01-01 – 2013-03-31 Source

Capital expenditure

1.71 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Capital expenditure: 1721109 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 1228979 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 2240612 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 1721109 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 2900588 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 2240612 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 38834 USD · 2013-01-01 – 2013-03-31 Source

Free cash flow

-45.7 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Operating cash flow: 28763392 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -27745465 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -4841756 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 28763392 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -38884582 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: -4841756 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -32838898 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 1721109 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 1228979 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 2240612 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 1721109 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 2900588 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 2240612 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 38834 USD · 2013-01-01 – 2013-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-08-07.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2012-12-31
Operating income: 9 of 11 periods available· newest 2012-12-31
Net income: 7 of 11 periods available· newest 2010-12-31
Operating cash flow: 9 of 11 periods available· newest 2012-12-31
Capital expenditure: 9 of 11 periods available· newest 2012-12-31
Total assets: 8 of 11 periods available· newest 2012-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2012-12-31
Current liabilities: 8 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2012-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-30%

Prior period

USD 144.98 million

2011-01-01 – 2011-12-31
Current period

USD 101.53 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

101531429 − 144978373 = -43446944 USD

144978373 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
101531429 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Year-over-year change in Revenue: -43446944 USD Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 101531429 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#184818 Filing: 000110465913021766 Input fundies:Revenue: 144978373 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#180851 Filing: 000110465913021766
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 20.11 million

Prior period

−USD 18.77 million

2011-01-01 – 2011-12-31
Current period

−USD 38.88 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-38884582 − -18773822 = -20110760 USD

-18773822 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-38884582 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Year-over-year change in Operating cash flow: -20110760 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -38884582 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#192857 Filing: 000110465913021766 Input fundies:OperatingCashFlow: -18773822 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#188730 Filing: 000110465913021766
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+18.9%

Prior period

USD 2.44 million

2011-01-01 – 2011-12-31
Current period

USD 2.9 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

2900588 − 2439718 = 460870 USD

2439718 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
2900588 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Year-over-year change in Capital expenditure: 460870 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2900588 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#2027165 Filing: 000110465913021766 Input fundies:CapitalExpenditure: 2439718 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#189820 Filing: 000110465913021766
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 101.53 million 100% of revenue
Cost of revenue USD 5.49 million 5.4% of revenue
Operating expenses USD 157.23 million 155% of revenue
Other operating costs Derived USD 29.65 million 29% of revenue
Operating income −USD 90.84 million −89% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −USD 38.88 million −38% of revenue
Capital expenditure USD 2.9 million 2.9% of revenue
Free cash flow Derived −USD 41.79 million −41% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Operating loss: operating costs were 1,014% of revenue.
2005 Operating loss: operating costs were 458% of revenue.
2006 Operating loss: operating costs were 1,501% of revenue.
2007 Operating loss: operating costs were 6,383% of revenue.
2008 Operating loss: operating costs were 3,730% of revenue.
2009 Operating loss: operating costs were 4,872% of revenue.
2010 Operating loss: operating costs were 3,401% of revenue.
2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	1110937	11268477 Derived	-10157540	-247465 Derived	-9910075	-9372885 Derived	Source 2004-01-01 – 2004-12-31: 1110937 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -10157540 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -9910075 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -9175219 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 197666 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	2146682	9828591 Derived	-7681909	-237088 Derived	-7444821	-5447222 Derived	Source 2005-01-01 – 2005-12-31: 2146682 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -7681909 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -7444821 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -5402479 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 44743 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	933090	14004145 Derived	-13071055	-1169160 Derived	-11901895	-8551795 Derived	Source 2006-01-01 – 2006-12-31: 933090 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -13071055 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -11901895 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -8505622 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 46173 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	767165	48967869 Derived	-48200704	-2061527 Derived	-46139177	-41428159 Derived	Source 2007-01-01 – 2007-12-31: 767165 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -48200704 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -46139177 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -41181833 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 246326 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	1023370	38169900 Derived	-37146530	-1561934 Derived	-35584596	-33476757 Derived	Source 2008-01-01 – 2008-12-31: 1023370 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -37146530 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -35584596 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -33268071 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 208686 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	892644	43490881 Derived	-42598237	-505680 Derived	-42092557	-39238273 Derived	Source 2009-01-01 – 2009-12-31: 892644 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -42598237 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -42092557 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -39022510 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 215763 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	1480362	50348555 Derived	-48868193	-1528451 Derived	-47339742	-41989894 Derived	Source 2010-01-01 – 2010-12-31: 1480362 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -48868193 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -47339742 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -41683902 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 305992 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	144978373	139339715 Derived	5638658	Unavailable	Unavailable	-21213540 Derived	Source 2011-01-01 – 2011-12-31: 144978373 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 5638658 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -18773822 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 2439718 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	101531429	192368253 Derived	-90836824	Unavailable	Unavailable	-41785170 Derived	Source 2012-01-01 – 2012-12-31: 101531429 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -90836824 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -38884582 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 2900588 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 101.5M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	1110937	Revenue: 1110937 Open source
20052005-12-31	Revenue	2146682	Revenue: 2146682 Open source
20062006-12-31	Revenue	933090	Revenue: 933090 Open source
20072007-12-31	Revenue	767165	Revenue: 767165 Open source
20082008-12-31	Revenue	1023370	Revenue: 1023370 Open source
20092009-12-31	Revenue	892644	Revenue: 892644 Open source
20102010-12-31	Revenue	1480362	Revenue: 1480362 Open source
20112011-12-31	Revenue	144978373	Revenue: 144978373 Open source
20122012-12-31	Revenue	101531429	Revenue: 101531429 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-30% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 1110937 Open source
20052005-12-31	Year over year	93.2%	Revenue: 2146682 Open source Revenue: 1110937 Open source
20062006-12-31	Year over year	-56.5%	Revenue: 933090 Open source Revenue: 2146682 Open source
20072007-12-31	Year over year	-17.8%	Revenue: 767165 Open source Revenue: 933090 Open source
20082008-12-31	Year over year	33.4%	Revenue: 1023370 Open source Revenue: 767165 Open source
20092009-12-31	Year over year	-12.8%	Revenue: 892644 Open source Revenue: 1023370 Open source
20102010-12-31	Year over year	65.8%	Revenue: 1480362 Open source Revenue: 892644 Open source
20112011-12-31	Year over year	9,693.4%	Revenue: 144978373 Open source Revenue: 1480362 Open source
20122012-12-31	Year over year	-30%	Revenue: 101531429 Open source Revenue: 144978373 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -89.5% 2012

Net margin -3,197.8% 2010

Free cash flow margin -41.2% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	-914.3%	Operating Income: -10157540 Open source Revenue: 1110937 Open source
20052005-12-31	Operating margin	-357.9%	Operating Income: -7681909 Open source Revenue: 2146682 Open source
20062006-12-31	Operating margin	-1,400.8%	Operating Income: -13071055 Open source Revenue: 933090 Open source
20072007-12-31	Operating margin	-6,283%	Operating Income: -48200704 Open source Revenue: 767165 Open source
20082008-12-31	Operating margin	-3,629.8%	Operating Income: -37146530 Open source Revenue: 1023370 Open source
20092009-12-31	Operating margin	-4,772.1%	Operating Income: -42598237 Open source Revenue: 892644 Open source
20102010-12-31	Operating margin	-3,301.1%	Operating Income: -48868193 Open source Revenue: 1480362 Open source
20112011-12-31	Operating margin	3.9%	Operating Income: 5638658 Open source Revenue: 144978373 Open source
20122012-12-31	Operating margin	-89.5%	Operating Income: -90836824 Open source Revenue: 101531429 Open source
20042004-12-31	Net margin	-892%	Net Income: -9910075 Open source Revenue: 1110937 Open source
20052005-12-31	Net margin	-346.8%	Net Income: -7444821 Open source Revenue: 2146682 Open source
20062006-12-31	Net margin	-1,275.5%	Net Income: -11901895 Open source Revenue: 933090 Open source
20072007-12-31	Net margin	-6,014.2%	Net Income: -46139177 Open source Revenue: 767165 Open source
20082008-12-31	Net margin	-3,477.2%	Net Income: -35584596 Open source Revenue: 1023370 Open source
20092009-12-31	Net margin	-4,715.5%	Net Income: -42092557 Open source Revenue: 892644 Open source
20102010-12-31	Net margin	-3,197.8%	Net Income: -47339742 Open source Revenue: 1480362 Open source
2011-12-31	Net margin	Not reported	Revenue: 144978373 Open source
2012-12-31	Net margin	Not reported	Revenue: 101531429 Open source
20042004-12-31	Free cash flow margin	-843.7%	Revenue: 1110937 Open source Operating Cash Flow: -9175219 Open source Capital Expenditure: 197666 Open source
20052005-12-31	Free cash flow margin	-253.8%	Revenue: 2146682 Open source Operating Cash Flow: -5402479 Open source Capital Expenditure: 44743 Open source
20062006-12-31	Free cash flow margin	-916.5%	Revenue: 933090 Open source Operating Cash Flow: -8505622 Open source Capital Expenditure: 46173 Open source
20072007-12-31	Free cash flow margin	-5,400.2%	Revenue: 767165 Open source Operating Cash Flow: -41181833 Open source Capital Expenditure: 246326 Open source
20082008-12-31	Free cash flow margin	-3,271.2%	Revenue: 1023370 Open source Operating Cash Flow: -33268071 Open source Capital Expenditure: 208686 Open source
20092009-12-31	Free cash flow margin	-4,395.7%	Revenue: 892644 Open source Operating Cash Flow: -39022510 Open source Capital Expenditure: 215763 Open source
20102010-12-31	Free cash flow margin	-2,836.5%	Revenue: 1480362 Open source Operating Cash Flow: -41683902 Open source Capital Expenditure: 305992 Open source
20112011-12-31	Free cash flow margin	-14.6%	Revenue: 144978373 Open source Operating Cash Flow: -18773822 Open source Capital Expenditure: 2439718 Open source
20122012-12-31	Free cash flow margin	-41.2%	Revenue: 101531429 Open source Operating Cash Flow: -38884582 Open source Capital Expenditure: 2900588 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -38.9M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-9175219	Operating Cash Flow: -9175219 Open source
20052005-12-31	Operating cash flow	-5402479	Operating Cash Flow: -5402479 Open source
20062006-12-31	Operating cash flow	-8505622	Operating Cash Flow: -8505622 Open source
20072007-12-31	Operating cash flow	-41181833	Operating Cash Flow: -41181833 Open source
20082008-12-31	Operating cash flow	-33268071	Operating Cash Flow: -33268071 Open source
20092009-12-31	Operating cash flow	-39022510	Operating Cash Flow: -39022510 Open source
20102010-12-31	Operating cash flow	-41683902	Operating Cash Flow: -41683902 Open source
20112011-12-31	Operating cash flow	-18773822	Operating Cash Flow: -18773822 Open source
20122012-12-31	Operating cash flow	-38884582	Operating Cash Flow: -38884582 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -41.8M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	-9372885	Operating Cash Flow: -9175219 Open source Capital Expenditure: 197666 Open source
20052005-12-31	Free cash flow	-5447222	Operating Cash Flow: -5402479 Open source Capital Expenditure: 44743 Open source
20062006-12-31	Free cash flow	-8551795	Operating Cash Flow: -8505622 Open source Capital Expenditure: 46173 Open source
20072007-12-31	Free cash flow	-41428159	Operating Cash Flow: -41181833 Open source Capital Expenditure: 246326 Open source
20082008-12-31	Free cash flow	-33476757	Operating Cash Flow: -33268071 Open source Capital Expenditure: 208686 Open source
20092009-12-31	Free cash flow	-39238273	Operating Cash Flow: -39022510 Open source Capital Expenditure: 215763 Open source
20102010-12-31	Free cash flow	-41989894	Operating Cash Flow: -41683902 Open source Capital Expenditure: 305992 Open source
20112011-12-31	Free cash flow	-21213540	Operating Cash Flow: -18773822 Open source Capital Expenditure: 2439718 Open source
20122012-12-31	Free cash flow	-41785170	Operating Cash Flow: -38884582 Open source Capital Expenditure: 2900588 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	No source recorded
2005-12-31	Liabilities / assets	Not reported	Total Assets: 32334816 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 24113916 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 60785540 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 42295498 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 40655990 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 52020162 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 182023172 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 159427322 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.67× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Current assets / current liabilities	Not reported	No source recorded
20052005-12-31	Current assets / current liabilities	14.44×	Current Assets: 30610458 Open source Current Liabilities: 2120236 Open source
20062006-12-31	Current assets / current liabilities	4.55×	Current Assets: 23053862 Open source Current Liabilities: 5063593 Open source
20072007-12-31	Current assets / current liabilities	7.86×	Current Assets: 59773593 Open source Current Liabilities: 7600177 Open source
20082008-12-31	Current assets / current liabilities	5.13×	Current Assets: 40071065 Open source Current Liabilities: 7813491 Open source
20092009-12-31	Current assets / current liabilities	5.05×	Current Assets: 38602332 Open source Current Liabilities: 7650909 Open source
20102010-12-31	Current assets / current liabilities	10.64×	Current Assets: 49932289 Open source Current Liabilities: 4692866 Open source
20112011-12-31	Current assets / current liabilities	5.66×	Current Assets: 177160723 Open source Current Liabilities: 31308006 Open source
20122012-12-31	Current assets / current liabilities	5.67×	Current Assets: 152015563 Open source Current Liabilities: 26787739 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 9.91 million Exact value Exact value: -9910075 USD 2004-01-01 – 2004-12-31: -9910075 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2004-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -9910075 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9910075 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-07-024395.txt#15811 The citation records this snapshot. The page link may show a newer release later.	−USD 9.18 million Exact value Exact value: -9175219 USD 2004-01-01 – 2004-12-31: -9175219 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2004-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -9175219 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9175219 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-07-024395.txt#16214 The citation records this snapshot. The page link may show a newer release later.	USD 197,666 Exact value Exact value: 197666 USD 2004-01-01 – 2004-12-31: 197666 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2004-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 197666 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 197666 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-07-024395.txt#16348 The citation records this snapshot. The page link may show a newer release later.	−USD 9.37 million Calculation and evidence -9175219 − 197666 USD Exact free cash flow: -9372885 USD 2004-01-01 – 2004-12-31: -9175219 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 197666 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2004-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -9372885 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9175219 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-07-024395.txt#16214 Input fundies:CapitalExpenditure: 197666 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-07-024395.txt#16348 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 7.44 million Exact value Exact value: -7444821 USD 2005-01-01 – 2005-12-31: -7444821 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2005-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -7444821 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7444821 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-08-019920.txt#16510 The citation records this snapshot. The page link may show a newer release later.	−USD 5.4 million Exact value Exact value: -5402479 USD 2005-01-01 – 2005-12-31: -5402479 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2005-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -5402479 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5402479 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-08-019920.txt#16913 The citation records this snapshot. The page link may show a newer release later.	USD 44,743 Exact value Exact value: 44743 USD 2005-01-01 – 2005-12-31: 44743 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2005-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 44743 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44743 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-08-019920.txt#17043 The citation records this snapshot. The page link may show a newer release later.	−USD 5.45 million Calculation and evidence -5402479 − 44743 USD Exact free cash flow: -5447222 USD 2005-01-01 – 2005-12-31: -5402479 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 44743 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2005-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -5447222 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5402479 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-08-019920.txt#16913 Input fundies:CapitalExpenditure: 44743 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-08-019920.txt#17043 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 11.9 million Exact value Exact value: -11901895 USD 2006-01-01 – 2006-12-31: -11901895 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2006-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -11901895 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11901895 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-09-017130.txt#15495 The citation records this snapshot. The page link may show a newer release later.	−USD 8.51 million Exact value Exact value: -8505622 USD 2006-01-01 – 2006-12-31: -8505622 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2006-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -8505622 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8505622 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-09-017130.txt#15898 The citation records this snapshot. The page link may show a newer release later.	USD 46,173 Exact value Exact value: 46173 USD 2006-01-01 – 2006-12-31: 46173 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2006-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 46173 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46173 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-09-017130.txt#16028 The citation records this snapshot. The page link may show a newer release later.	−USD 8.55 million Calculation and evidence -8505622 − 46173 USD Exact free cash flow: -8551795 USD 2006-01-01 – 2006-12-31: -8505622 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 46173 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2006-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -8551795 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8505622 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-09-017130.txt#15898 Input fundies:CapitalExpenditure: 46173 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-09-017130.txt#16028 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 46.14 million Exact value Exact value: -46139177 USD 2007-01-01 – 2007-12-31: -46139177 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2007-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -46139177 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46139177 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-10-013737.txt#11644 The citation records this snapshot. The page link may show a newer release later.	−USD 41.18 million Exact value Exact value: -41181833 USD 2007-01-01 – 2007-12-31: -41181833 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2007-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -41181833 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41181833 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-10-013737.txt#16165 The citation records this snapshot. The page link may show a newer release later.	USD 246,326 Exact value Exact value: 246326 USD 2007-01-01 – 2007-12-31: 246326 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2007-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 246326 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 246326 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-10-013737.txt#16295 The citation records this snapshot. The page link may show a newer release later.	−USD 41.43 million Calculation and evidence -41181833 − 246326 USD Exact free cash flow: -41428159 USD 2007-01-01 – 2007-12-31: -41181833 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 246326 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2007-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -41428159 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41181833 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-10-013737.txt#16165 Input fundies:CapitalExpenditure: 246326 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-10-013737.txt#16295 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 35.58 million Exact value Exact value: -35584596 USD 2008-01-01 – 2008-12-31: -35584596 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2008-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -35584596 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35584596 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#4993 The citation records this snapshot. The page link may show a newer release later.	−USD 33.27 million Exact value Exact value: -33268071 USD 2008-01-01 – 2008-12-31: -33268071 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2008-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -33268071 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33268071 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#6697 The citation records this snapshot. The page link may show a newer release later.	USD 208,686 Exact value Exact value: 208686 USD 2008-01-01 – 2008-12-31: 208686 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2008-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 208686 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 208686 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#6782 The citation records this snapshot. The page link may show a newer release later.	−USD 33.48 million Calculation and evidence -33268071 − 208686 USD Exact free cash flow: -33476757 USD 2008-01-01 – 2008-12-31: -33268071 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 208686 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2008-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -33476757 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33268071 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#6697 Input fundies:CapitalExpenditure: 208686 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#6782 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 42.09 million Exact value Exact value: -42092557 USD 2009-01-01 – 2009-12-31: -42092557 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2009-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -42092557 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42092557 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#4993 The citation records this snapshot. The page link may show a newer release later.	−USD 39.02 million Exact value Exact value: -39022510 USD 2009-01-01 – 2009-12-31: -39022510 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2009-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -39022510 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39022510 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465912016656/optr-20111231.xml#64493 Filing: 000110465912016656 The citation records this snapshot. The page link may show a newer release later.	USD 215,763 Exact value Exact value: 215763 USD 2009-01-01 – 2009-12-31: 215763 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2009-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 215763 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 215763 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465912016656/optr-20111231.xml#65935 Filing: 000110465912016656 The citation records this snapshot. The page link may show a newer release later.	−USD 39.24 million Calculation and evidence -39022510 − 215763 USD Exact free cash flow: -39238273 USD 2009-01-01 – 2009-12-31: -39022510 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 215763 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2009-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -39238273 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39022510 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465912016656/optr-20111231.xml#64493 Filing: 000110465912016656 Input fundies:CapitalExpenditure: 215763 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465912016656/optr-20111231.xml#65935 Filing: 000110465912016656 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 47.34 million Exact value Exact value: -47339742 USD 2010-01-01 – 2010-12-31: -47339742 USD Inspect Net Income Open source Share or cite Citation for Net Income · OPTIMER PHARMACEUTICALS INC · 2010-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Net Income: -47339742 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47339742 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/0001104659-11-013601.txt#4993 The citation records this snapshot. The page link may show a newer release later.	−USD 41.68 million Exact value Exact value: -41683902 USD 2010-01-01 – 2010-12-31: -41683902 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2010-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -41683902 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41683902 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#188945 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	USD 305,992 Exact value Exact value: 305992 USD 2010-01-01 – 2010-12-31: 305992 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2010-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 305992 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 305992 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#189993 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	−USD 41.99 million Calculation and evidence -41683902 − 305992 USD Exact free cash flow: -41989894 USD 2010-01-01 – 2010-12-31: -41683902 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 305992 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2010-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -41989894 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41683902 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#188945 Filing: 000110465913021766 Input fundies:CapitalExpenditure: 305992 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#189993 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unavailable Not reported for this period.	−USD 18.77 million Exact value Exact value: -18773822 USD 2011-01-01 – 2011-12-31: -18773822 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2011-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -18773822 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18773822 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#188730 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	USD 2.44 million Exact value Exact value: 2439718 USD 2011-01-01 – 2011-12-31: 2439718 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2011-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 2439718 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2439718 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#189820 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	−USD 21.21 million Calculation and evidence -18773822 − 2439718 USD Exact free cash flow: -21213540 USD 2011-01-01 – 2011-12-31: -18773822 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 2439718 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2011-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -21213540 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18773822 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#188730 Filing: 000110465913021766 Input fundies:CapitalExpenditure: 2439718 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#189820 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	−USD 38.88 million Exact value Exact value: -38884582 USD 2012-01-01 – 2012-12-31: -38884582 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Operating Cash Flow: -38884582 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38884582 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#192857 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	USD 2.9 million Exact value Exact value: 2900588 USD 2012-01-01 – 2012-12-31: 2900588 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Capital Expenditure: 2900588 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2900588 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#2027165 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.	−USD 41.79 million Calculation and evidence -38884582 − 2900588 USD Exact free cash flow: -41785170 USD 2012-01-01 – 2012-12-31: -38884582 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 2900588 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OPTIMER PHARMACEUTICALS INC · 2012-12-31 OPTIMER PHARMACEUTICALS INC (edgar:1142576) Free cash flow: -41785170 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:45:39Z Snapshot: 97562582d39135ff804f7ed1cb829f61e2bcf45cc81be2d82d9a24ee2b564062 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1142576?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38884582 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#192857 Filing: 000110465913021766 Input fundies:CapitalExpenditure: 2900588 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1142576/000110465913021766/optr-20121231.xml#2027165 Filing: 000110465913021766 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 674 latest values · 674 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001142576, 1142576, edgar:1142576

Also known as OPTIMER PHARMACEUTICALS INC

OPTIMER PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation